Neuroendocrine neoplasm: A 10-year retrospective review of a single-center experience. Second interim analysis of CABONEN: An international, multicenter phase II trial investigating cabozantinib in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results